Nurse Education, Practice, Quality and Retention Simulation Education Training Program
Funding to enhance nursing education and strengthen the nursing workforce through experiential learning opportunities, including the use of simulation-based technology to improve the health of patients, families, and communities in rural and medically underserved areas experiencing diseases and conditions that affect public health. Geographic coverage: Nationwide -- Health Resources and Services Administration, U.S. Department of Health and Human Services (Source: AIDS and HIV funding opportunities via the Rural Assistance Center)
Source: AIDS and HIV funding opportunities via the Rural Assistance Center - April 6, 2020 Category: Infectious Diseases Source Type: funding

Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-026 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to continue to provide operations support for Biosafety Level 4 (BSL4) facilities to the National Biocontainment Laboratories at the University of Texas Medical Branch (UTMB) in Galveston, Texas and Boston University in Boston, Massachusetts. Operations support is provided in the following areas: facility maintenance and operations; biosecurity; environmental health and safety regulations and requirements; regulatory compliance; and specialized research support services. The NBLs will s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 6, 2020 Category: Research Source Type: funding

Notice of Special Interest: NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed)
Notice NOT-ES-20-014 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 27, 2020 Category: Research Source Type: funding

Notice of Clarification of Additional Considerations listed in NIAID RFA-AI-20-009, Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed)
Notice NOT-AI-20-039 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 17, 2020 Category: Research Source Type: funding

Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)
Funding Opportunity RFA-AI-20-028 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate therapeutics, vaccines and related countermeasures against select NIAID Emerging Infectious Diseases/Pathogens. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 11, 2020 Category: Research Source Type: funding

Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-009 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will establish Human Biomimetics for Infectious Diseases Cooperative Research Centers (Biomimetics CRCs) focused on multidisciplinary research advancing and/or developing innovative in vitro human-cell- or -tissue-derived three-dimensional (3D) models for basic and translational research on infectious diseases. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 25, 2020 Category: Research Source Type: funding

Vaccine and Treatment Evaluation Units (VTEUs): Enhancing Capability and Capacity (UM1 Clinical Trial Required)
Funding Opportunity RFA-AI-20-021 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit applications for the Vaccine and Treatment Evaluation Units (VTEUs) to implement clinical site protocols (clinical research, clinical trials) for evaluating vaccines, other preventive biologics, therapeutics, diagnostics, including prognostic and predictive markers, and devices for the treatment and prevention of infectious diseases as part of NIAID Infectious Diseases Clinical Research Consortium (IDCRC). A companion FOA solicits applications for the Leadership Group for the In...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 19, 2020 Category: Research Source Type: funding

International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-108 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of high-priority, regionally relevant infectious disease research by international investigators in resource-constrained countries. Applicant organizations must be headquartered in foreign (non-U.S.) resource-constrained countries (i.e. low-income economies, lower-middle-income economies, and upper-middle-income economies by World Bank Classification). Eligibility status of applicant organizations will be determined by this World Bank Classification li...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 4, 2020 Category: Research Source Type: funding

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
Funding Opportunity PAR-20-063 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID), invites applications for investigator-initiated Resource-Related Research Projects (R24). The proposed resource must provide a significant benefit to currently funded high priority projects in need of further coordination and support in the areas specified. Under rare circumstances, this mechanism may be used to support development of a new resource to the broader scientific community of the NIAID. It is anticipated that the re...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2019 Category: Research Source Type: funding

Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-HD-20-020 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to address the needs of the maternal and pediatric HIV scientific community for research data translation and sharing. This initiative will support secondary data analyses using archived HIV/AIDS data and specimens to generate new research questions and findings relevant to the scientific mission and priorities of the NICHD, Maternal and Pediatric Infectious Disease Branch(MPIDB) and Office of AIDS Research (OAR). The goal of this initiative is to continue the encouragement of the sc...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 6, 2019 Category: Research Source Type: funding

Ecology and Evolution of Infectious Diseases (EEID) Program 2019 US-UK, China and Israel call for proposals
(Source: MRC Funding Opportunities)
Source: MRC Funding Opportunities - September 5, 2019 Category: Research Source Type: funding

Planning Grant for Global Infectious Disease Research Training Program (D71 No Clinical Trials Allowed)
Funding Opportunity PAR-19-362 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for a planning grant from institutions in low- and middle-income countries (LMICs) to 1.) Design a Global Infectious Disease (GID) Research Training Program in collaboration with U.S. collaborators and 2.) Strengthen LMIC faculty and prepare advanced courses and training resources for the program envisioned at the LMIC institution. The application should propose a collaborative process to create a new training program that will strengthen the capacity of the LMIC institution to co...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 3, 2019 Category: Research Source Type: funding

Notice of NIH Participation in the Ecology and Evolution of Infectious Diseases Program
Notice NOT-TW-19-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 28, 2019 Category: Research Source Type: funding

Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-351 from the NIH Guide for Grants and Contracts. The National Institute of Allergy and Infectious Diseases (NIAID) announces a program that provides NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for Exploratory and Developmental Research Grant (R21) support at some point during the final two years of their K award. Through the use of this mechanism, NIAID seeks to enhance the capability of its K01, K08, and K23 award recipients to conduct research as they complete their transition to fully independent investigator status (e.g., R01 support). The R21 grant mechanism s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 20, 2019 Category: Research Source Type: funding

MRC-AMED Infectious Disease Research Collaboration
(Source: MRC Funding Opportunities)
Source: MRC Funding Opportunities - June 17, 2019 Category: Research Source Type: funding

Sample Grant Applications, Summary Statements, and More
If you are new to writing grant applications, sometimes seeing how someone else has presented their idea can help as you are developing your own application. With the gracious permission of successful investigators, the National Institute of Allergy and Infectious Diseases (NIAID) makes available examples of funded R01, R03, R15, R21, SBIR/STTR, K, and F applications, summary statements, sharing plans, leadership plans, and more. When referencing these resources, it is important to remember: These applications were developed using the application forms and instructions that were in effect at the time of their submission...
Source: NIH Extramural Nexus - May 1, 2019 Category: Research Authors: NIH Staff Tags: Tips Before You Submit grant tips sample application Source Type: funding

SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-19-009 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to further the development of Advanced Technology Training (ATT) products for: the health and safety training of hazardous materials (HAZMAT) workers; waste treatment personnel; skilled support personnel associated with an emergency/disaster; emergency responders in biosafety response, infectious disease training and cleanup; emergency responders in disasters and resiliency training...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 30, 2019 Category: Research Source Type: funding

Notice of Budget Change in RFA-AI-19-028 Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed)
Notice NOT-AI-19-056 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 4, 2019 Category: Research Source Type: funding

U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01 Clinical Trial Optional)
Funding Opportunity RFA-AI-19-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue the U.S.-South Africa Program for Collaborative Biomedical Research into Phase 2. Research areas supported under this program include: tuberculosis; sexually transmitted infections; parasitic infections; arboviruses and emerging/re-emerging viral pathogens; and vector biology and control. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2019 Category: Research Source Type: funding

U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (U01 Clinical Trial Optional)
Funding Opportunity RFA-AI-19-025 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to continue the U.S.-South Africa Program for Collaborative Biomedical Research into Phase 2. Research areas supported under this program include: tuberculosis; sexually transmitted infections; parasitic infections; arboviruses and emerging/re-emerging viral pathogens; and vector biology and control. This opportunity is specifically designed to promote partnerships between eligible NIH Intramural Research Program (IRP) investigators (e.g. those conducting research within the laborato...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2019 Category: Research Source Type: funding

Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-19-028 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to establish a coordinated network of Emerging Infectious Disease Research Centers (EIDRCs) in regions around the globe where emerging and re-emerging infectious disease outbreaks are likely to occur. Multidisciplinary teams of investigators will conduct pathogen/host surveillance, study pathogen transmission, pathogenesis and immunologic responses in the host, and will develop reagents and diagnostic assays for improved detection for important emerging pathogens and their vectors. (...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 5, 2019 Category: Research Source Type: funding

Emerging Infectious Diseases Research Centers - Coordination Center (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-19-029 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for an Emerging Infectious Diseases Research Centers Coordination Center (EIDRC CC) for the Emerging Infectious Diseases Research Centers (EIDRC). The EIDRC CC will oversee and coordinate select aspects of each EIDRCs research project(s) involving data management, sample collection and storage, sharing of reagents, diagnostics, and resources, and will facilitate collaboration between the newly awarded EIDRCs, and other USG and international agencies, as approp...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 4, 2019 Category: Research Source Type: funding

U.S.-Brazil Collaborative Biomedical Research Program (R01 Clinical Trial Optional)
Funding Opportunity RFA-AI-18-054 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote collaborative biomedical research between the United States and Brazil under the U.S.-Brazil Biomedical Collaborative Research Program. Research areas supported under this program include allergy, immunology, and infectious diseases, including HIV/AIDS and its co-morbidities; cancer; mother-to-child transmission of HIV and other congenital infections, early infant diagnosis and treatment; HIV/AIDS in relation to mental health; and neurological disorders and stroke. (Source...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 4, 2018 Category: Research Source Type: funding

Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed)
Funding Opportunity PA-19-068 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support projects that utilize open-access data, alone or in combination with other datasets, to address knowledge gaps in basic and clinical infectious diseases. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 13, 2018 Category: Research Source Type: funding

Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed)
Funding Opportunity PA-19-066 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to determine antigen processing and presentation mechanisms used in the generation of novel peptidic and non-peptidic ligands and to determine the contribution of these unique antigenic ligands to protective immune responses against infectious disease pathogens and/or vaccines; pathogen-associated immune pathogenesis; and/or limit progression or induction of immune-mediated diseases. These studies may facilitate the development of novel tools and reagents to advance design of immune-b...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 13, 2018 Category: Research Source Type: funding

Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21 Clinical Trials Optional)
Funding Opportunity PAR-19-059 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports planning, design and initial pilots for locally relevant and catalytic research on non-communicable diseases (NCDs) or injury in low and middle-income countries (LMICs). Research addressing multiple NCDs and their risk factors and research addressing NCDs as comorbidities for/with infectious diseases including HIV/AIDS is encouraged. Scientists in the United States (U.S.) or upper middle income countries (UMICs) are eligible to partner with scientists in LMIC institutions. Income categories used...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 7, 2018 Category: Research Source Type: funding

Request for Information (RFI): Soliciting Input on the National Institutes of Allergy and Infectious Diseases (NIAID) New Innovator Awards (DP2 Clinical Trials Optional)
Notice NOT-AI-19-013 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 5, 2018 Category: Research Source Type: funding

What Contributes to the Success of Early Career Scientists? – A NIAID Look
At NIH, we are heavily invested in our workforce and in understanding the barriers they face. What characteristics do they share? How do they compete in the current hypercompetitive environment? When do they stop applying to NIH (drop out), even after receiving their first award? Staff from the National Institute of Allergy and Infectious Diseases (NIAID) delve into these questions in a paper published recently in PLOS ONE , whose findings I’d like to highlight today. Here, Drs. Patricia Haggerty and Matthew Fenton looked at factors that may contribute to the success of early-career investigators and if these factors...
Source: NIH Extramural Nexus - October 31, 2018 Category: Research Authors: Mike Lauer Tags: blog Open Mike Uncategorized biomedical research workforce Biomedical Workforce Early Stage Investigators Funding data funding rate Source Type: funding

Notice of NIH Participation in the Ecology and Evolution of Infectious Diseases Program
Notice NOT-TW-18-005 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 23, 2018 Category: Research Source Type: funding

Notice of Webinar and FAQs for NIAID Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required) and Leadership Group for an Infectious Diseases Clinical Research Consortium (IDCRC) (UM1 Clinical Trial Required), RFA-AI-18-046 and RFA-AI-18-047
Notice NOT-AI-19-008 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 18, 2018 Category: Research Source Type: funding

Request for proposal (rfp): bioinformatics resource centers for infectious diseases, rfp-niaid-dmid-nihai201800005
Notice NOT-AI-19-009 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 15, 2018 Category: Research Source Type: funding

Notice of Webinar and FAQs for NIAID Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required) and Leadership Group for an Infectious Diseases Clinical Research Consortium (IDCRC) (UM1 Clinical Trial Required), RFA-AI-18-046 and RFA-AI-18-047
Notice NOT-AI-18-060 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 1, 2018 Category: Research Source Type: funding

Vaccine and Treatment Evaluation Units (VTEUs) (UM1 Clinical Trial Required)
Funding Opportunity RFA-AI-18-046 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit applications for the Vaccine Treatment and Evaluation Units (VTEUs) to implement clinical site protocols (clinical research, clinical trials) for evaluating vaccines, other preventive biologics, therapeutics, diagnostics, including prognostic and predictive markers, and devices for the treatment and prevention of infectious diseases as part of NIAID Infectious Diseases Clinical Research Consortium (IDCRC). A companion FOA solicits applications for the Leadership Group for the In...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 1, 2018 Category: Research Source Type: funding

Leadership Group for an Infectious Diseases Clinical Research Consortium (IDCRC) (UM1 Clinical Trial Required)
Funding Opportunity RFA-AI-18-047 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to form a Leadership Group for an Infectious Diseases Clinical Research Consortium, hereafter referred to as the Leadership Group (LG), to support the planning and implementation of clinical research that addresses the scientific priorities of NIAID in evaluating vaccines, other preventive biologics, therapeutics, diagnostics, including prognostic and predictive markers, and devices for the treatment and prevention of infectious diseases. A companion FOA solic...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 1, 2018 Category: Research Source Type: funding

HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional)
Funding for NIH high priority research relevant to drug misuse and HIV/AIDS. Research priorities revolve around the National Institute on Drug Abuse's Seek, Test, Treat, and Retain framework, and include reducing health disparities in the incidence of new HIV infections or in treatment outcomes of those living with HIV/AIDS. Populations of interest include urban, suburban, and rural drug users; populations at elevated risk for HIV, such as men who have sex with men; and people in rural areas who use opioids and injection drugs. Geographic coverage: Nationwide -- National Institute on Drug Abuse, National Institutes of Heal...
Source: AIDS and HIV funding opportunities via the Rural Assistance Center - September 12, 2018 Category: Infectious Diseases Source Type: funding

Minnesota Eliminating Health Disparities Initiative (EHDI) Grant Program
Funding for projects focused on improving the health and well-being of American Indians and people of color in Minnesota. Geographic coverage: Minnesota -- Minnesota Department of Health (Source: AIDS and HIV funding opportunities via the Rural Assistance Center)
Source: AIDS and HIV funding opportunities via the Rural Assistance Center - September 7, 2018 Category: Infectious Diseases Source Type: funding

Southern HIV Impact Fund Urgent Action Grants
Grants for community-based and social justice organizations and coalitions in the south working in the areas of HIV prevention; care and support; and policy, advocacy, and movement building. Geographic coverage: Alabama, Florida, Georgia, Louisiana, Mississippi, North Carolina, South Carolina, Tennessee, and Texas -- AIDS United (Source: AIDS and HIV funding opportunities via the Rural Assistance Center)
Source: AIDS and HIV funding opportunities via the Rural Assistance Center - August 31, 2018 Category: Infectious Diseases Source Type: funding

Ecology and Evolution of Infectious Diseases (EEID)
Available Formats: HTML: https://www.nsf.gov/pubs/2018/nsf18581/nsf18581.htm?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2018/nsf18581/nsf18581.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf18581This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - August 18, 2018 Category: Science Source Type: funding

Notice of Change to the Research Areas of Focus for PAR-17-267 "Modeling of Infectious Disease Agent Study Research Projects (R01)"
Notice NOT-AI-18-039 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 9, 2018 Category: Research Source Type: funding

Elucidating the Functional Roles of Non-Coding RNAs in Viral Infectious Diseases (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-18-025 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support exploratory and developmental research projects to uncover functional roles of non-coding RNAs (ncRNAs) in viral infectious diseases. Importantly, the projects should focus on functional characterization and mechanistic studies of previously identified ncRNAs. Applications limited to the discovery or identification of ncRNAs will not be supported under this RFA. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 28, 2018 Category: Research Source Type: funding

Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 - Clinical Trial Optional)
Funding Opportunity PA-18-838 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research related to the role of the gut microbiome in regulating metabolism and reproduction, and its impact on the fertility status. The overarching goal is to gain fundamental insight into the possible role of the gut microbiome in regulating reproduction through HPG, HPA, and HPT axes in the brain. The results of the study could lead to development of diagnostic markers (signature microbiomes) for reproduct...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 26, 2018 Category: Research Source Type: funding

Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional)
Funding Opportunity PA-18-839 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research related to the role of the gut microbiome in regulating metabolism and reproduction, and its impact on the fertility status. The overarching goal is to gain fundamental insight into the possible role of the gut microbiome in regulating reproduction through HPG, HPA, and HPT axes in the brain. The results of the study could lead to development of diagnostic markers (signature microbiomes) for reproduct...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 26, 2018 Category: Research Source Type: funding

Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
Funding Opportunity PAR-18-840 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for the Global Infectious Disease (GID) Research Training Program from U.S. and low- and middle-income country (LMIC) institutions. The application should propose a collaborative training program that will strengthen the capacity of an LMIC institution to conduct infectious disease research. FIC will support research-training programs that focus on major endemic or life-threatening emerging infectious diseases, neglected tropical diseases, infections that frequently occur as co-in...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 26, 2018 Category: Research Source Type: funding

Notice of Change to Eligible Organizations in NIAID PAR-18-335 Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
Notice NOT-AI-18-041 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 19, 2018 Category: Research Source Type: funding

UK-Indonesia Joint Partnership on Infectious Diseases
(Source: MRC Funding Opportunities)
Source: MRC Funding Opportunities - May 23, 2018 Category: Research Source Type: funding

Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)
Funding Opportunity RFA-HD-19-018 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to address the needs of the maternal and pediatric HIV scientific community for research data translation and sharing. This initiative will support secondary data analyses using archived HIV/AIDS data and specimens to generate new research questions and findings relevant to the scientific mission and priorities of the NICHD, Maternal and Pediatric Infectious Disease Branch (MPIDB) and Office of AIDS Research (OAR). The goal of this initiative is to encourage applicants to leverage ex...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 14, 2018 Category: Research Source Type: funding

SBIR E-learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-18-006 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to further the development of Advanced Technology Training (ATT) products for the health and safety training of hazardous materials (HAZMAT) workers; skilled support personnel; emergency responders in biosafety response, infectious disease training and cleanup; emergency responders in disasters and resiliency training; and for ATT tools to assist in research into the acute and long-...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 25, 2018 Category: Research Source Type: funding

Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01)
Research grants that address patient adherence to treatment and prevention regimens to promote positive health outcomes. Clinical trials are optional. Geographic coverage: Nationwide -- National Cancer Institute, National Center for Complementary and Integrative Health, National Institute of Allergy and Infectious Diseases, National Institute of Mental Health, National Institute of Nursing Research, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, National Institute on Minority Health and Health Disparities, National Institutes of Health, U.S. Department of ...
Source: AIDS and HIV funding opportunities via the Rural Assistance Center - March 28, 2018 Category: Infectious Diseases Source Type: funding

Coordination Center for the Models of Infectious Disease Agent Study (MIDAS) Program (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-GM-18-003 from the NIH Guide for Grants and Contracts. The Coordination Center for the Models of Infectious Disease Agent Study (MIDAS) program will serve as a hub for collaboration, testing and dissemination of research products from the network of MIDAS investigators. The Coordination Center will also serve as the primary repository for MIDAS related datasets, models and software. The Coordination Center will maintain, promote and maximize utility and use of the shared MIDAS resources. In addition, the Program Director(s)/Principal Investigator(s) of the Coordination Center will proactively devel...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 28, 2018 Category: Research Source Type: funding

Genomic Centers for Infectious Diseases (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-18-004 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support Genomic Centers for Infectious Diseases (GCID) to promote broad use and expand the application of genomics technologies and computational analysis to understand infectious diseases, with an emphasis on pathogens, their interaction with the host and microbiome, and to aid in the development of novel genomics-based tools to diagnose, prevent and treat infectious diseases. The GCID will support innovative technology development in all aspects of genomics, including the use of synthetic and genome editin...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2018 Category: Research Source Type: funding